Current Report Filing (8-k)
May 17 2018 - 6:34AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM
8-K
CURRENT
REPORT
Pursuant to Section 13 or 15(d)
of The Securities Exchange Act of 1934
Date of Report (date of earliest event reported): May 17, 2018
QUORUM HEALTH CORPORATION
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
001-37550
|
|
47-4725208
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
|
|
1573 Mallory Lane, Brentwood, Tennessee
|
|
37027
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrants telephone number, including area code:
(615) 221-1400
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form
8-K
filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions (see General Instruction A.2. below):
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule
14a-12
under the Exchange Act (17 CFR
240.14a-12)
|
☐
|
Pre-commencement
communications pursuant to Rule
14d-2(b)
under the Exchange Act (17 CFR
240.14d-2(b))
|
☐
|
Pre-commencement
communications pursuant to Rule
13e-4(c)
under the Exchange Act (l7 CFR
240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging growth company as
defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule
12b-2
of the Securities Exchange Act of 1934
(§240.12b-2
of this chapter).
Emerging growth company ☐
If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange
Act. ☐
The information contained in this Current Report on Form
8-K
(including the exhibit hereto) shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or incorporated by
reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing.
Item 7.01
|
Regulation FD Disclosure
|
Quorum Health Corporation (the Company) prepared
an investor presentation (the Presentation) containing financial and operational highlights and certain other information. The Company expects to use the Presentation, in whole or in part, in connection with presentations to investors,
analysts and others commencing as soon as May 17, 2018. A copy of the Presentation is attached hereto as Exhibit 99.1 and is incorporated herein by reference. A copy of the Presentation is also available on the Investor Relations section of the
Companys website.
Item 9.01
|
Financial Statements and Exhibits
|
(d) Exhibits
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
Date: May 17, 2018
|
|
|
|
QUORUM HEALTH CORPORATION
|
|
|
|
|
(Registrant)
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Alfred Lumsdaine
|
|
|
|
|
|
|
Alfred Lumsdaine
|
|
|
|
|
|
|
Executive Vice President and Chief Financial Officer
|
|
|
|
|
|
|
(principal financial officer and principal accounting officer)
|
Quorum Health (NYSE:QHC)
Historical Stock Chart
From Aug 2024 to Sep 2024
Quorum Health (NYSE:QHC)
Historical Stock Chart
From Sep 2023 to Sep 2024